415692-67-0 Usage
Uses
Used in Pharmaceutical Industry:
N-(3,4-dimethoxyphenyl)-4-methylbenzamide is used as a pharmaceutical intermediate for the development of new drugs due to its unique chemical structure and potential medicinal properties. Its specific role in drug synthesis and the treatment of various conditions are still being explored and investigated.
Used in Organic Synthesis:
In the field of organic synthesis, N-(3,4-dimethoxyphenyl)-4-methylbenzamide serves as a valuable intermediate. Its presence in the synthesis process can lead to the creation of a variety of complex organic compounds, contributing to the advancement of chemical research and the development of novel substances with potential applications in various industries.
Used in Research and Development:
N-(3,4-dimethoxyphenyl)-4-methylbenzamide is employed in research and development settings to study its potential medicinal properties and applications. Scientists and researchers are actively investigating its uses and effects, with the aim of uncovering new ways to harness its potential benefits in the medical and pharmaceutical sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 415692-67-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,5,6,9 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 415692-67:
(8*4)+(7*1)+(6*5)+(5*6)+(4*9)+(3*2)+(2*6)+(1*7)=160
160 % 10 = 0
So 415692-67-0 is a valid CAS Registry Number.
415692-67-0Relevant articles and documents
Rhodium-Catalyzed Synthesis of Amides from Functionalized Blocked Isocyanates
Beauchemin, André M.,Derasp, Joshua S.
, p. 8104 - 8109 (2019/08/26)
Isocyanates are useful building blocks for the synthesis of amides, although their widespread use has been limited by their high reactivity, which often results in poor functional group tolerance and a propensity to oligomerize. Herein, a rhodium-catalyzed synthesis of amides is described coupling boroxines with blocked (masked) isocyanates. The success of the reaction hinges on the ability to form both the isocyanate and the organorhodium intermediates in situ. Relying on masked isocyanate precursors and on the high reactivity of the organorhodium intermediate results in broad functional group tolerance, including protic nucleophilic groups such as amines, anilines, and alcohols.
BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS
-
Page/Page column 11, (2009/03/07)
The present invention relates to methods of treating CNS disorders with a compound of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification and pharmaceutically acceptable acid addition salts thereof.
